Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001735276-20-000076
Filing Date
2020-07-06
Accepted
2020-07-06 16:50:56
Documents
2
Period of Report
2020-07-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 3552
2 EDGAR SUPPORTING DOCUMENT schulman_20200701poa.txt EX-24 4088
  Complete submission text file 0001735276-20-000076.txt   9160
Mailing Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142
Business Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Issuer) CIK: 0001178670 (see all company filings)

EIN.: 770602661 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address PFIZER INC. ATTN: CORPORATE SECRETARY 235 EAST 42ND STREET NEW YORK NY 10017
Business Address
SCHULMAN AMY W (Reporting) CIK: 0001438226 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36407 | Film No.: 201014035